05/2009 - Državni zavod za intelektualno vlasništvo

1984 HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 5, 1863 – 2065MKP Broj objave europske Naziv izumaprijave patenta(51) (97) (54)A61K 31/415 (2006.01) EP 2051978 * ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTORUSEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETOA61K 31/4155 (2006.01) EP 2046774 * PYRAZOLE DERIVATIVES AS CYTOCHROME P450 INHIBITORSA61K 31/416 (2006.01) EP 2054390 * INDAZOLE DERIVATIVES THAT INHIBIT TRPV1 AND USES THEREOFA61K 31/4164 (2006.01) EP 2054404 * IMIDAZOLE COMPOUNDS HAVING AN ANTIINFLAMMATORY EFFECTA61K 31/4166 (2006.01) EP 2049107 * SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATION AND USESA61K 31/4178 (2006.01) EP 2049522 * HEPATITIS C VIRUS INHIBITORSA61K 31/4184 (2006.01) EP 2046756 * PREPARATION OF TELMISARTAN SALTSA61K 31/4184 (2006.01) EP 2049107 * SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATION AND USESA61K 31/4184 (2006.01) EP 2049510 * PROCESS FOR THE PREPARATION OF CANDESARTAN CILEXETIL FORM IA61K 31/4184 (2006.01) EP 2051967 * BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATMENT OF VALLINOID RECEPTORTRPV1 RELATED DISORDERSA61K 31/4196 (2006.01) EP 2049472 * CYCLOPROPYL AMINE DERIVATIVES AS HISTAMIN H3 RECEPTOR MODULATORSA61K 31/4196 (2006.01) EP 2050446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/4196 (2006.01) EP 2054059 * TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITYA61K 31/423 (2006.01) EP 2050446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/423 (2006.01) EP 2051714 * DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASESA61K 31/423 (2006.01) EP 2054059 * TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITYA61K 31/425 (2006.01) EP 2046746 * CHEMICAL COMPOUNDSA61K 31/426 (2006.01) EP 2046766 * AGONISTS OF THE SPHINGOSINE- 1- PHOSPHATE RECEPTOR (SLP)A61K 31/426 (2006.01) EP 2049092 * COMPOSITIONS WITH ENHANCED ELASTICIZING ACTIVITYA61K 31/426 (2006.01) EP 2050446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/426 (2006.01) EP 2054059 * TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITYA61K 31/427 (2006.01) EP 2046298 * PHARMACEUTICALLY ACCEPTABLE SOLUBILIZING COMPOSITION ANDPHARMACEUTICAL DOSAGE FORM CONTAINING SAMEA61K 31/427 (2006.01) EP 2046786 * POLYMORPHIC FORMS OF ZIPRASIDONE SULFATESA61K 31/427 (2006.01) EP 2049506 * MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICSA61K 31/427 (2006.01) EP 2051990 * SMAC PEPTIDOMIMETICS USEFUL AS IAP INHIBITORSA61K 31/433 (2006.01) EP 2046746 * CHEMICAL COMPOUNDSA61K 31/433 (2006.01) EP 2046766 * AGONISTS OF THE SPHINGOSINE- 1- PHOSPHATE RECEPTOR (SLP)A61K 31/435 (2006.01) EP 1927595 Salts of clopidogrel and process for preparationA61K 31/435 (2006.01) EP 2046775 * N-(AMINOHETEROARYL)-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, PREPARATIONTHEREOF AND THERAPEUTIC USE THEREOFA61K 31/435 (2006.01) EP 2049484 * ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIASA61K 31/435 (2006.01) EP 2049537 * 1, 7-NAPHTHYRIDINE DERIVATIVES AS P38 MAP KINASE INHIBITORSA61K 31/435 (2006.01) EP 2050737 * EXHIBITING PSYCHOTROPIC (ANTIDEPRESSANT AND ANXYOLYTIC),NEUROPROTECTIVE, HEROPROTECTIVE AND CEREBROPROTECTIVE ACTIONMONO-AND DIVALENT SALTS OF N-(5-HYDROXYNICOTINOIL)-L-GLUTAMINIC ACIDA61K 31/435 (2006.01) EP 2051975 * SUBSTITUTED PROLINAMIDES, PRODUCTION THEREOF AND THEIR USE AS DRUGSA61K 31/435 (2006.01) EP 2051983 * NTETRAHYDROPYRIDOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF CANCERA61K 31/435 (2006.01) EP 2054402 * AN AMINOISOQUINOLINE THROMBIN INHIBITOR WITH IMPROVED BIOAVAILABILITYA61K 31/435 (2006.01) EP 2054404 * IMIDAZOLE COMPOUNDS HAVING AN ANTIINFLAMMATORY EFFECTA61K 31/4365 (2006.01) EP 2049472 * CYCLOPROPYL AMINE DERIVATIVES AS HISTAMIN H3 RECEPTOR MODULATORSA61K 31/437 (2006.01) EP 2046787 * PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORSA61K 31/437 (2006.01) EP 2049534 * PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PDE4 INHIBITORSA61K 31/437 (2006.01) EP 2050449 * AQUEOUS LIQUID PREPARATION CONTAINING AMIDE COMPOUNDA61K 31/44 (2006.01) EP 2046746 * CHEMICAL COMPOUNDSA61K 31/44 (2006.01) EP 2050446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/44 (2006.01) EP 2051707 * INHIBITORS OF PLASMA KALLIKREINA61K 31/44 (2006.01) EP 2053042 Pyridine compounds for the treatment of prostaglandin mediated diseasesA61K 31/44 (2006.01) EP 2054076 * COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONSA61K 31/44 (2006.01) EP 2054380 * TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, AND THEIR PREPARATION AND USEA61K 31/4402 (2006.01) EP 2050446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/4406 (2006.01) EP 2050446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/4412 (2006.01) EP 2046328 * PYRIDINONE DIKETO ACIDS: INHIBITORS OF HIV REPLICATION IN COMBINATIONTHERAPYA61K 31/4412 (2006.01) EP 2049084 * NANOPARTICULATE SORAFENIB FORMULATIONSA61K 31/4427 (2006.01) EP 2046774 * PYRAZOLE DERIVATIVES AS CYTOCHROME P450 INHIBITORSA61K 31/443 (2006.01) EP 2046774 * PYRAZOLE DERIVATIVES AS CYTOCHROME P450 INHIBITORSISSN 1331-2030